阿兹夫定致窦性心动过速二例

Two cases of sinus tachycardia induced by azvudine tablets

阿兹夫定作为我国首个自主研发的抗新型冠状病毒感染的口服小分子药,已被用于临床治疗新型冠状病毒感染。本文报道了2例患者在应用阿兹夫定后出现心动过速,经对症治疗后症状缓解的案例,提示临床在应用阿兹夫定时应警惕心脏不良反应的发生,做到严密监测,早发现、早治疗,提高药物使用的安全性。

Azvudine has been used in clinical treatment of novel coronavirus pneumonia,which is the first self-devel?oped oral small-molecule drug against the novel coronavirus in China.Two patients developed tachycardia after the applica?tion of azivudine tablets,and the symptoms were relieved after supported treatment.It suggested that the occurrence of adverse cardiac reactions should be vigilant in the clinical application of azvudine tablets.In the addition,close monitoring as well as early detection and treatment should be taken to improve the safety of drug use.